HomeROQ • LON
add
Roquefort Therapeutics PLC
Previous close
GBX 2.10
Day range
GBX 1.70 - GBX 2.14
Year range
GBX 1.08 - GBX 6.78
Market cap
2.99M GBP
Avg Volume
2.58M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 246.70K | -25.49% |
Net income | -245.07K | 15.42% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -245.35K | 27.36% |
Effective tax rate | 7.87% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 182.92K | -69.29% |
Total assets | 5.66M | -6.78% |
Total liabilities | 909.12K | -20.58% |
Total equity | 4.75M | — |
Shares outstanding | 157.44M | — |
Price to book | 0.70 | — |
Return on assets | -10.89% | — |
Return on capital | -12.01% | — |
Cash Flow
Net change in cash
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -245.07K | 15.42% |
Cash from operations | -164.78K | 37.17% |
Cash from investing | -28.43K | -29,717.71% |
Cash from financing | 118.00K | -59.65% |
Net change in cash | -77.10K | -364.30% |
Free cash flow | -188.20K | 7.80% |
About
Founded
2020
Website
Employees
7
